These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 22379847)
1. [Comparative analysis of surgical and medical treatment of macroprolactinoma of different localization]. Astaf'eva LI; Kadashev BA; Dedov II; Kalinin PL; Kutin MA; Shkaburo AN; Fomichev DV; Tenedieva VD; Tropinskaia OF Zh Vopr Neirokhir Im N N Burdenko; 2011; 75(4):3-9; discussion 9. PubMed ID: 22379847 [TBL] [Abstract][Full Text] [Related]
2. Falsely low serum prolactin in two cases of invasive macroprolactinoma. Schöfl C; Schöfl-Siegert B; Karstens JH; Bremer M; Lenarz T; Cuarezma JS; Samii M; von zur Mühlen A; Brabant G Pituitary; 2002; 5(4):261-5. PubMed ID: 14558675 [TBL] [Abstract][Full Text] [Related]
4. [Cost-effectiveness analysis of two therapeutic methods for prolactinoma]. Zhen JR; Yu Q; Zhang YH; Ma WB; Lin SQ Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):257-61. PubMed ID: 18843964 [TBL] [Abstract][Full Text] [Related]
12. Giant invasive prolactinoma: a case report and review of nine further cases. Davis JR; Sheppard MC; Heath DA Q J Med; 1990 Mar; 74(275):227-38. PubMed ID: 2385731 [TBL] [Abstract][Full Text] [Related]
13. Prolactinoma and body weight: a retrospective study. Creemers LB; Zelissen PM; van 't Verlaat JW; Koppeschaar HP Acta Endocrinol (Copenh); 1991 Oct; 125(4):392-6. PubMed ID: 1957557 [TBL] [Abstract][Full Text] [Related]
14. Prolactinoma with preferential infrasellar extension: a report of two cases. Nishio S; Morioka T; Fujiwara S; Fukui M J Clin Neurosci; 2001 May; 8(3):287-9. PubMed ID: 11386812 [TBL] [Abstract][Full Text] [Related]
16. [The impact of prolactinoma in human reproduction]. Hurtado Amador R; Ayala AR; Hernández Marín I Ginecol Obstet Mex; 2004 Jan; 72(1):3-9. PubMed ID: 15239558 [TBL] [Abstract][Full Text] [Related]
17. Giant prolactinomas: clinical manifestations and outcomes of 16 Arab cases. Almalki MH; Buhary B; Alzahrani S; Alshahrani F; Alsherbeni S; Alhowsawi G; Aljohani N Pituitary; 2015 Jun; 18(3):405-9. PubMed ID: 25062894 [TBL] [Abstract][Full Text] [Related]
18. Prolactin ≤1 ng/mL predicts macroprolactinoma reduction after cabergoline therapy. Kim D; Ku CR; Kim K; Jung H; Lee EJ Eur J Endocrinol; 2020 Feb; 182(2):177-183. PubMed ID: 31770105 [TBL] [Abstract][Full Text] [Related]
19. Giant invasive pituitary prolactinoma with falsely low serum prolactin: the significance of 'hook effect'. Fleseriu M; Lee M; Pineyro MM; Skugor M; Reddy SK; Siraj ES; Hamrahian AH J Neurooncol; 2006 Aug; 79(1):41-3. PubMed ID: 16598425 [TBL] [Abstract][Full Text] [Related]
20. Rapid re-enlargement of a macroprolactinoma after initial shrinkage in a young woman treated with bromocriptine. Adler I; Barsi P; Czirják S; Varga I; Gergics P; Jakab C; Rácz K Gynecol Endocrinol; 2005 Jun; 20(6):317-21. PubMed ID: 16019380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]